Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Scortechini

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Expert Opinion on Biological Therapy|July 14, 2012
Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient programMassimo Martino, Mauro Montanari, Benedetto Bruno, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo StudyElena Marinelli Busilacchi, Andrea Costantini, Nadia Viola, et al.
Leukemia & Lymphoma|September 13, 2013
Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphomaIlaria Scortechini, Mauro Montanari, Giorgia Mancini, et al.
Clinical Hematology International|December 23, 2021
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic EvaluationGiuseppe Tarantino, Francesco Saraceni, Giorgia Mancini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2014
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicinDebora Capelli, Martina Chiarucci, Antonella Poloni, et al.
European Journal of Haematology|April 9, 2013
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemiaAlessia Dalsass, Francesca Mestichelli, Miriana Ruggieri, et al.
Transfusion|June 21, 2013
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphomaFrancesco Lanza, Roberto M Lemoli, Attilio Olivieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 5, 2014
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective studyMassimo Martino, Mauro Montanari, Felicetto Ferrara, et al.
Blood Advances|October 25, 2024
COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?Francesco Autore, Andrea Visentin, Marina Deodato, et al.
Hematological Oncology|March 4, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in ItalyFrancesco Autore, Andrea Visentin, Candida Vitale, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Expert Opinion on Biological Therapy|July 14, 2012
Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient programMassimo Martino, Mauro Montanari, Benedetto Bruno, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo StudyElena Marinelli Busilacchi, Andrea Costantini, Nadia Viola, et al.
Leukemia & Lymphoma|September 13, 2013
Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphomaIlaria Scortechini, Mauro Montanari, Giorgia Mancini, et al.
Clinical Hematology International|December 23, 2021
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic EvaluationGiuseppe Tarantino, Francesco Saraceni, Giorgia Mancini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2014
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicinDebora Capelli, Martina Chiarucci, Antonella Poloni, et al.
European Journal of Haematology|April 9, 2013
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemiaAlessia Dalsass, Francesca Mestichelli, Miriana Ruggieri, et al.
Transfusion|June 21, 2013
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphomaFrancesco Lanza, Roberto M Lemoli, Attilio Olivieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 5, 2014
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective studyMassimo Martino, Mauro Montanari, Felicetto Ferrara, et al.
Blood Advances|October 25, 2024
COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?Francesco Autore, Andrea Visentin, Marina Deodato, et al.
Hematological Oncology|March 4, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in ItalyFrancesco Autore, Andrea Visentin, Candida Vitale, et al.
Pageof 4